RESTORATION OF BIOMARKER LEVELS IN ISCHEMIC STROKE

dc.contributor.authorGazieva Sh. R.
dc.date.accessioned2025-12-28T10:43:43Z
dc.date.issued2025-08-31
dc.description.abstractTo quickly assess the condition and develop an individual treatment plan in patients with ischemic stroke and low levels of PLA2G2E, DGLA, and PADI4 biomarkers, it is recommended to use the Rankine, Rivermead, MoСА and NIHSS scales. Studies have also established the effectiveness of correcting standard therapy for ischemic stroke by including the nootropic oxiracetam, the dietary supplement GLA, the restoring deficiency of DGLA and the anticoagulant rivaroxaban, which significantly reduce the duration and adverse outcomes of rehabilitation compared with conventional therapy.
dc.formatapplication/pdf
dc.identifier.urihttps://usajournals.org/index.php/1/article/view/883
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/4054
dc.language.isoeng
dc.publisherModern American Journals
dc.relationhttps://usajournals.org/index.php/1/article/view/883/956
dc.rightshttps://creativecommons.org/licenses/by/4.0
dc.sourceModern American Journal of Medical and Health Sciences; Vol. 1 No. 5 (2025); 104-113
dc.source3067-803X
dc.subjectIschemic stroke, PLA2G2E, DGLA and PADI4, D-dimer, miR-210.
dc.titleRESTORATION OF BIOMARKER LEVELS IN ISCHEMIC STROKE
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
r_2025_restoration_of_biomarker_levels_in_ische.pdf
item.page.filesection.size
782.44 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections